Literature DB >> 25375928

Ubiquitination in disease pathogenesis and treatment.

Doris Popovic1, Domagoj Vucic2, Ivan Dikic3.   

Abstract

Ubiquitination is crucial for a plethora of physiological processes, including cell survival and differentiation and innate and adaptive immunity. In recent years, considerable progress has been made in the understanding of the molecular action of ubiquitin in signaling pathways and how alterations in the ubiquitin system lead to the development of distinct human diseases. Here we describe the role of ubiquitination in the onset and progression of cancer, metabolic syndromes, neurodegenerative diseases, autoimmunity, inflammatory disorders, infection and muscle dystrophies. Moreover, we indicate how current knowledge could be exploited for the development of new clinical therapies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25375928     DOI: 10.1038/nm.3739

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  168 in total

Review 1.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 2.  Assembly of k11-linked ubiquitin chains by the anaphase-promoting complex.

Authors:  Michael Rape
Journal:  Subcell Biochem       Date:  2010

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

5.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

6.  IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.

Authors:  Jennifer M Sacheck; Akira Ohtsuka; S Christine McLary; Alfred L Goldberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-04-20       Impact factor: 4.310

7.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Authors:  Christina M Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

9.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

10.  Structure of HHARI, a RING-IBR-RING ubiquitin ligase: autoinhibition of an Ariadne-family E3 and insights into ligation mechanism.

Authors:  David M Duda; Jennifer L Olszewski; Jonathan P Schuermann; Igor Kurinov; Darcie J Miller; Amanda Nourse; Arno F Alpi; Brenda A Schulman
Journal:  Structure       Date:  2013-05-23       Impact factor: 5.006

View more
  329 in total

Review 1.  Using protein motion to read, write, and erase ubiquitin signals.

Authors:  Aaron H Phillips; Jacob E Corn
Journal:  J Biol Chem       Date:  2015-09-09       Impact factor: 5.157

2.  A new duet in cancer biology: AMPK the typical and UBE2O the atypical.

Authors:  Isabelle K Vila; Su Jung Song; Min Sup Song
Journal:  Mol Cell Oncol       Date:  2017-03-17

Review 3.  Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.

Authors:  Haiqi Lu; Guangliang Li; Chenyi Zhou; Wei Jin; Xiaoling Qian; Zhuo Wang; Hongming Pan; Hongchuan Jin; Xian Wang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

4.  Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice.

Authors:  James B Papizan; Alexander H Vidal; Svetlana Bezprozvannaya; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Biol Chem       Date:  2018-04-13       Impact factor: 5.157

5.  Modulation of conformational equilibrium by phosphorylation underlies the activation of deubiquitinase A.

Authors:  Ashish Kabra; Efsita Rumpa; Ying Li
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

Review 6.  The COP9 signalosome and cullin-RING ligases in the heart.

Authors:  Xuejun Wang; Douglas S Martin
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

7.  Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects.

Authors:  Elizabeth M Ellison; Melissa A Bradley-Whitman; Mark A Lovell
Journal:  J Mol Neurosci       Date:  2017-09-02       Impact factor: 3.444

8.  Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis.

Authors:  Wassim A Basheer; Brett S Harris; Heather L Mentrup; Measho Abreha; Elizabeth L Thames; Jessica B Lea; Deborah A Swing; Neal G Copeland; Nancy A Jenkins; Robert L Price; Lydia E Matesic
Journal:  J Mol Cell Cardiol       Date:  2015-09-16       Impact factor: 5.000

9.  Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes.

Authors:  Christopher M Rose; Marta Isasa; Alban Ordureau; Miguel A Prado; Sean A Beausoleil; Mark P Jedrychowski; Daniel J Finley; J Wade Harper; Steven P Gygi
Journal:  Cell Syst       Date:  2016-09-22       Impact factor: 10.304

10.  Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity.

Authors:  Zongyang Lv; Katelyn M Williams; Lingmin Yuan; James H Atkison; Shaun K Olsen
Journal:  J Biol Chem       Date:  2018-10-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.